Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH Dosage Exploration in Short Stature
NCT06768411Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Open-label trial of peg-somatropin in short stature (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Height growth rate at 2 years. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
peg-somatropin
03
Conditions
short stature
Beyond the preview
Go deeper on NCT06768411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06768411.